Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Bioanalysis|November 19, 2010
Bioanalysis of meningococcal vaccinesNeil Ravenscroft, Jun X Wheeler, Christopher JonesProteomics. Clinical Applications|December 8, 2010
Proteomic analysis of the response of the human neutrophil-like cell line NB-4 after exposure to anthrax lethal toxinJun X Wheeler, Gail Whiting, Sjoerd RijpkemaHuman Vaccines & Immunotherapeutics|March 19, 2014
Identification of peptide sequences as a measure of Anthrax vaccine stability during storageGail Whiting, Jun X Wheeler, Sjoerd RijpkemaProteomics. Clinical Applications|December 8, 2010
Exploring the proteome of meningococcal outer membrane vesicle vaccinesJun X Wheeler, Caroline Vipond, Ian M FeaversAnalytical Biochemistry|October 13, 2021
Quantitation of thrombin-activatable fibrinolysis inhibitor in human plasma by isotope dilution mass spectrometryJun X Wheeler, Craig Thelwell, Peter Rigsby, et al.Proteomics. Clinical Applications|December 8, 2010
Proteomics analysis of cellular components in lentiviral vector production using Gel-LC-MS/MSJun X Wheeler, Christopher Jones, Robin Thorpe, et al.Vaccine|December 17, 2019
Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometryGail Whiting, Caroline Vipond, Alessandra Facchetti, et al.Human Vaccines|October 14, 2006
Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometryCaroline Vipond, Jun X Wheeler, Christopher Jones, et al.Vaccine|July 19, 2015
In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccineSarah M Connaughton, Jun X Wheeler, Eva Vitková, et al.Biologicals : Journal of the International Association of Biological Standardization|January 24, 2018
Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectorsSabine Johnson, Jun X Wheeler, Robin Thorpe, et al.Pageof 3